These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26581074)

  • 1. Metabolism and metabolite profiles in vitro and in vivo of ospemifene in humans and preclinical species.
    Uusitalo J; Turpeinen M; Tolonen A; Koskimies P; Lammintausta R; Pelkonen O
    Drug Metab Pers Ther; 2016 Mar; 31(1):35-40. PubMed ID: 26581074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations.
    Tolonen A; Koskimies P; Turpeinen M; Uusitalo J; Lammintausta R; Pelkonen O
    Drug Metabol Drug Interact; 2013; 28(3):153-61. PubMed ID: 23729558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P450 inhibitors and inducers on the metabolism and pharmacokinetics of ospemifene.
    Lehtinen T; Tolonen A; Turpeinen M; Uusitalo J; Vuorinen J; Lammintausta R; Pelkonen O; Scheinin M
    Biopharm Drug Dispos; 2013 Oct; 34(7):387-95. PubMed ID: 23852652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ospemifene on drug metabolism mediated by cytochrome P450 enzymes in humans in vitro and in vivo.
    Turpeinen M; Uusitalo J; Lehtinen T; Kailajärvi M; Pelkonen O; Vuorinen J; Tapanainen P; Stjernschantz C; Lammintausta R; Scheinin M
    Int J Mol Sci; 2013 Jul; 14(7):14064-75. PubMed ID: 23880855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for predicting effects of unintended environmental exposure to an endocrine active pharmaceutical, tamoxifen.
    Mills LJ; Henderson WM; Jayaraman S; Gutjahr-Gobell RE; Zaroogian GE; Horowitz DB; Laws SC
    Environ Toxicol; 2016 Dec; 31(12):1834-1850. PubMed ID: 26303313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the formation of vabicaserin carbamoyl glucuronide.
    Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose and steady-state pharmacokinetics of ospemifene, a selective estrogen receptor modulator, in postmenopausal women.
    Koskimies P; Turunen J; Lammintausta R; Scheinin M
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):861-7. PubMed ID: 24075094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in metabolism of panomifene, an analogue of tamoxifen.
    Monostory K; Jemnitz K; Vereczkey L; Czira G
    Drug Metab Dispos; 1997 Dec; 25(12):1370-8. PubMed ID: 9394026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
    Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
    Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies variation in phase I metabolism of bufalin in hepatic microsomes from mouse, rat, dog, minipig, monkey, and human.
    Ning J; Hou J; Wang P; Wu JJ; Dai ZR; Zou LW; Li W; Ge GB; Ma XC; Yang L
    Xenobiotica; 2015; 45(11):954-60. PubMed ID: 26053559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolic profiles of motolimod by using liquid chromatography tandem mass spectrometry: Metabolic stability, metabolite characterization and species comparison.
    Li Z; Zhao S; Yuan Y; Zhang L; Song Z; Tian X; Zhang X
    J Pharm Biomed Anal; 2019 Apr; 167():90-99. PubMed ID: 30763883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.
    Unkila M; Kari S; Yatkin E; Lammintausta R
    J Steroid Biochem Mol Biol; 2013 Nov; 138():107-15. PubMed ID: 23665515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.
    Burich RA; Mehta NR; Wurz GT; McCall JL; Greenberg BE; Bell KE; Griffey SM; DeGregorio MW
    Menopause; 2012 Jan; 19(1):96-103. PubMed ID: 21926925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans.
    Dean BJ; Chang S; Silva Elipe MV; Xia YQ; Braun M; Soli E; Zhao Y; Franklin RB; Karanam B
    Drug Metab Dispos; 2007 Feb; 35(2):283-92. PubMed ID: 17132765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
    Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
    Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
    Valles B; Schiller CD; Coassolo P; De Sousa G; Wyss R; Jaeck D; Viger-Chougnet A; Rahmani R
    Drug Metab Dispos; 1995 Oct; 23(10):1051-7. PubMed ID: 8654192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of ospemifene in the breast.
    Berga SL
    Reprod Sci; 2013 Oct; 20(10):1130-6. PubMed ID: 23945733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human.
    Wang P; Zhao Y; Zhu Y; Sun J; Yerke A; Sang S; Yu Z
    J Pharm Biomed Anal; 2016 Feb; 119():166-74. PubMed ID: 26683990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.